Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > # of NR Patients in Swimmer Plots (May 10th & May 30th)

<< Previous

Bullboard Posts

Next >>

Comment by NotinKansason May 31, 2023 9:16am

192 Views

Post# 35472053

RE:# of NR Patients in Swimmer Plots (May 10th & May 30th)

Hi RH, I think it is one from the three patients on lines 23-25 in 10 May’s plot (CR at 90 days, NR after that). There's only two of them reappearing in the 30 May plot (line 26-27). Seems quite a feat (having 4 assessments swapped from NR to CR), but must be one of them: all other NRs at 450 days from 10 May reappear unchanged as NR in yesterday's plot.

With these kind of corrections, revisions or whatever they are still going on apparently, it is perhaps no surprise that work on the BTD application (again apparently) is still ongoing.

<< Previous

Bullboard Posts

Next >>

Catch up with companies that got a Stanley Cup Playoffs boost